A Comprehensive Standard Operating Procedure (SOP) for H9C2 Cell Culture and Related Precautions

H9C2 cells are rat cardiomyoblasts, a widely‑used adherent cell model for investigating myocardial injury, oxidative stress and cardiovascular‑related research. These cells exhibit an elongated spindle‑shaped morphology, displaying strict adherence to culture surfaces with minimal intercellular gaps and occasional minor local multilayering and cell aggregation. H9C2 cells are sensitive to serum quality and glucose concentrations in culture medium. Improper passaging density frequently leads to cell stacking, senescence and dysregulated differentiation. Cell status is highly susceptible to environmental conditions, experimental manipulation and serum quality. This document outlines standardized workflows and practical guidance for H9C2 cell culture.

1. Cell Thawing

1. Preparation: Pre‑warm a water bath to 37 °C; pre‑heat 9 mL complete culture medium at 37 °C; irradiate the biosafety cabinet with ultraviolet light for 30 min in advance.
2. Thawing: Retrieve the cryovial from liquid nitrogen, swirl rapidly in the 37 °C water bath for 1–2 min until contents are completely thawed.
3. Resuspension: Wipe the exterior of the cryovial with 75% ethanol. Open the vial inside the biosafety cabinet, and slowly add the cell suspension drop‑wise into a 15 mL centrifuge tube containing 9 mL pre‑warmed complete medium.
4. Centrifugation: Centrifuge at 600 rpm for 5 min and discard the supernatant.
5. Resuspension: Add 1 mL complete medium and gently pipette the suspension 10 times. Label a new 10 cm culture dish on its lid with cell identity, operator, passage number and date. Add 9 mL complete medium followed by 1 mL cell suspension. Mix thoroughly by cross‑shaking to achieve uniform cell distribution across the dish surface.
6. Incubation: Place the dish inside the cell incubator for cultivation.

2. Cell Passaging

1. Experimental Preparation: Prepare complete medium: DMEM (Cat. No. abs9483‑500 mL) supplemented with 10% fetal bovine serum (FBS, Cat. No. abs972‑500 mL) and 1% penicillin‑streptomycin (P/S, Cat. No. abs9244‑100 mL). Equilibrate PBS (Cat. No. abs962‑500 mL), complete medium and 0.25% trypsin‑EDTA solution (Cat. No. abs47047375‑100 mL) to room temperature. Irradiate the biosafety cabinet with ultraviolet light for 30 min beforehand.
2. Microscopic examination: Observe cells under a light microscope. Perform passaging when cell density reaches approximately 80% with well‑preserved cellular morphology.
3. Cell washing: Aspirate spent medium. Slowly add 2 mL PBS along the inner wall of the culture dish. Gently rock the dish to ensure full coverage of PBS, then remove PBS by aspiration.
   Note: If abundant floating dead cells are observed under microscopy, repeat the PBS‑washing step once more.
4. Cell dissociation: Add 1 mL trypsin solution, rock the dish gently for even coverage of trypsin, and incubate at 37 °C for 1–2 min.
5. Cell collection: Terminate digestion immediately by adding 2 mL serum‑containing complete medium once cells become rounded, retracted and show enlarged intercellular spaces under microscopy. Gently pipette across the dish bottom to dislodge adherent cells and transfer the cell suspension into a 15 mL centrifuge tube.
6. Centrifugation: Centrifuge at 1000 rpm for 5 min and discard the supernatant. Add 2 mL complete medium and perform gentle pipetting 10‑15 times to resuspend the cell pellet.
   Note: The recommended splitting ratio for H9C2 cells ranges from 1:3 to 1:4. Adjust the volume of complete medium according to the splitting ratio.
7. Sub‑culturing: Label a new 10 cm culture dish on its lid with cell identity, operator, passage number and date. Add 9 mL complete medium and then 1 mL cell suspension. Homogenize via cross‑shaking for even cell distribution.
8. Post‑plating microscopic check: Examine cell morphology and distribution under a microscope. Incubate cells at 37 °C with 5% CO₂. Monitor cell status every 24 h.
   Note: Avoid full confluency of H9C2 cells. Dense monolayers cause multilayering, senescence and dysregulated differentiation due to weak contact‑inhibition; prolonged high‑density static culture must be avoided. Pass cells at ~80% confluency, with at least 2‑3 passages per week. H9C2 cells are sensitive to FBS. Premium‑grade FBS and high‑glucose DMEM are recommended; low‑glucose medium inhibits cell proliferation.

3. Cell Cryopreservation

1. Preparation: Serum‑free cryopreservation medium (Cat. No. abs9417‑100 mL) can be used; alternatively, prepare custom freezing medium consisting of 90% FBS (Cat. No. abs972‑500 mL) plus 10% DMSO (Cat. No. abs9187‑100 mL). Pre‑label cryovials with cell identity, passage number, operator and cryopreservation date. Irradiate the biosafety cabinet with ultraviolet light for 30 min.
   Note: H9C2 cells are sensitive to cryopreservation density; prepare 2‑3 cryovials per 10 cm dish.
2. Cell collection: Harvest cells at ~80% confluency following the passaging workflow. Centrifuge at 600 rpm and discard supernatant.
3. Cell resuspension: Add 3 mL cryopreservation medium and gently pipette to resuspend cell pellets.
4. Cryostorage: Aliquot 1 mL cell suspension into each cryovial. Place vials inside a freezing container and store at −80 °C overnight. Subsequently transfer vials into liquid‑nitrogen tanks for long‑term preservation.

4. Critical Precautions

1. Strict control of passaging density

Avoid full confluency of H9C2 cells. High‑density monolayers trigger cell stacking, senescence and aberrant differentiation as a result of weak contact‑inhibition; long‑term static culture at high cell density is prohibited. Passage cells at approximately 80% confluency, performing 2‑3 passages weekly at minimum.

2. Selection of serum and culture medium

1. H9C2 cells exhibit high sensitivity to fetal bovine serum; premium‑grade serum is recommended for cultivation.
2. Use high‑glucose DMEM; low‑glucose formulations suppress cell proliferation.
3. A gradient serum‑adaptation procedure is advised when switching to a different batch or brand of serum.

3. Contamination prevention

H9C2 cells are susceptible to mycoplasma infection, manifested as retarded proliferation, deteriorated cell morphology and unexplained cell floating. Perform regular mycoplasma testing and maintain strict aseptic techniques throughout all experimental manipulations.

5. absin Fetal Bovine Serum

Product Advantages

1. Serum brand under Univ (Uni‑V);
2. Cited in nearly 300 peer‑reviewed publications, with maximum impact factor of 32.4;
3. Routinely adopted in research groups led by academicians;
4. Validated across nearly 20 cell types; performance comparable to leading imported brands;
5. Low endotoxin level ＜3 EU/mL, low hemoglobin content ＜50 mg/L;
6. Sufficient single‑batch production capacity and minimal batch‑to‑batch variation;
7. Professional technical support and customized cell‑culture SOP guidance;
8. Aliquot service for 50 mL small‑volume packaging;
9. Diverse serum grades to facilitate experimental progress.

Contact Absin

Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

Absin Bioscience Inc. worldwide@absin.cn

Follow us on Facebook: Absin Bio